Background: |
High expression and prognostic value of TMEM45A has been recently reported in various types of human tumors. High levels of TMEM45A expression in tumors may be indicative of potential resistance to cancer therapy, making TMEM45A an interesting biomarker for resistance. |
Applications: |
ELISA, IHC |
Name of antibody: |
TMEM45A |
Immunogen: |
Synthetic peptide of human TMEM45A |
Full name: |
transmembrane protein 45A |
Synonyms: |
DERP7; DNAPTP4 |
SwissProt: |
Q9NWC5 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human cervical cancer and Human tonsil |
IHC Recommend dilution: |
25-100 |